Lynx1 Capital Management »

Nuvation Bio shares owned by Lynx1 Capital Management

Quarter-by-quarter ownership of Nuvation Bio (NUVB) shares owned by Lynx1 Capital Management from 13F filings

Historical chart of Lynx1 Capital Management investment in Nuvation Bio

Tip: Access up to 7 years of quarterly data

All positions including Nuvation Bio held by Lynx1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvation Bio by Lynx1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $91k 16k 5.68

More positions owned by Lynx1 Capital Management

Gh Research Ordinary Shares (GHRS)
Cullinan Oncology (CGEM)
Stoke Therapeutics (STOK)
Agios Pharmaceuticals (AGIO)
C4 Therapeutics Com Stk (CCCC)
Korro Bio (KRRO)
Tscan Therapeutics (TCRX)
Precision Biosciences Com New (DTIL)
Neuphoria Therapeutics (NEUP)
Passage Bio Com New (PASG)
Cg Oncology (CGON)
Pliant Therapeutics (PLRX)
Entrada Therapeutics (TRDA)
Vyne Therapeutics (VYNE)
Proqr Thrapeutics N V Shs Euro (PRQR)

View all positions for Lynx1 Capital Management

Top funds holding Nuvation Bio

FMR
BlackRock
Decheng Capital
Vanguard Capital Management
Omega Fund Management
Laurion Capital Management
UBS Group
State Street Corporation
Geode Capital Management
Duquesne Family Office
American Century Companies
Bank of America Corporation
Tang Capital Management
Redmile Group
Vanguard Portfolio Management

View all funds holding Nuvation Bio